Because there may be significant benefits to individuals and to society as a whole that are not reflected in the device pricing, there exists a potential loss to patients and to society that may not be recognized if and when devices and therapies are not commercialized due to the apparent insufficient ROI to investors.
← all excerpts
Societal return on investment may greatly exceed financial return on investment in neurotechnology-based therapies: A case study in epilepsy therapy development.
1
—
—